These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31231766)

  • 21. Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease).
    Chauty A; Ardant MF; Adeye A; Euverte H; Guédénon A; Johnson C; Aubry J; Nuermberger E; Grosset J
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4029-35. PubMed ID: 17526760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mycobacterium ulcerans disease management in Australian patients: the re-emergence of surgery as an important treatment modality.
    O'Brien DP; Callan P; Friedman ND; Athan E; Hughes A; McDonald A
    ANZ J Surg; 2019 Jun; 89(6):653-658. PubMed ID: 30239097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of mycolactone in human subcutaneous tissue during antibiotic therapy for Mycobacterium ulcerans disease.
    Sarfo FS; Phillips RO; Zhang J; Abass MK; Abotsi J; Amoako YA; Adu-Sarkodie Y; Robinson C; Wansbrough-Jones MH
    BMC Infect Dis; 2014 Apr; 14():202. PubMed ID: 24731247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcomes of Ghanaian Buruli ulcer patients who defaulted from antimicrobial therapy.
    Klis S; Kingma RA; Tuah W; van der Werf TS; Stienstra Y
    Trop Med Int Health; 2016 Sep; 21(9):1191-6. PubMed ID: 27456068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay.
    Converse PJ; Almeida DV; Tyagi S; Xu J; Nuermberger EL
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31036687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The surgical management of lesions of ulcerans infections due to Mycobacterium ulcerans, revisited.
    Radford AJ
    Trans R Soc Trop Med Hyg; 2009 Oct; 103(10):981-4. PubMed ID: 19457527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment and prevention of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: guideline update.
    O'Brien DP; Jenkin G; Buntine J; Steffen CM; McDonald A; Horne S; Friedman ND; Athan E; Hughes A; Callan PP; Johnson PD
    Med J Aust; 2014 Mar; 200(5):267-70. PubMed ID: 24641151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Paradoxical reactions and responses during antibiotic treatment for Mycobacterium ulcerans infection (Buruli ulcer). Four cases from French Guiana].
    Sambourg E; Dufour J; Edouard S; Morris A; Mosnier E; Reynaud Y; Sainte-Marie D; Nacher M; Guégan JF; Couppié P
    Ann Dermatol Venereol; 2014; 141(6-7):413-8. PubMed ID: 24951139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?
    Converse PJ; Nuermberger EL; Almeida DV; Grosset JH
    Future Microbiol; 2011 Oct; 6(10):1185-98. PubMed ID: 22004037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans.
    Etuaful S; Carbonnelle B; Grosset J; Lucas S; Horsfield C; Phillips R; Evans M; Ofori-Adjei D; Klustse E; Owusu-Boateng J; Amedofu GK; Awuah P; Ampadu E; Amofah G; Asiedu K; Wansbrough-Jones M
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3182-6. PubMed ID: 16048922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview: Development of Drugs Against Mycobacterium ulcerans.
    Pluschke G; Röltgen K
    Methods Mol Biol; 2022; 2387():185-187. PubMed ID: 34643912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Providing insight into the incubation period of Mycobacterium ulcerans disease: two case reports.
    Amoako YA; Frimpong M; Awuah DO; Plange-Rhule G; Boakye-Yiadom E; Agbavor B; Sarpong F; Ahor H; Adu E; Danso KG; Abass MK; Asiedu K; Wansbrough-Jones M; Phillips RO
    J Med Case Rep; 2019 Jul; 13(1):218. PubMed ID: 31315637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for recurrent Mycobacterium ulcerans disease after exclusive surgical treatment in an Australian cohort.
    O'Brien DP; Walton A; Hughes AJ; Friedman ND; McDonald A; Callan P; Rhadon R; Holten I; Athan E
    Med J Aust; 2013 May; 198(8):436-9. PubMed ID: 23641995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy-associated changes of histopathological features of Mycobacterium ulcerans lesions in a Buruli ulcer mouse model.
    Ruf MT; Schütte D; Chauffour A; Jarlier V; Ji B; Pluschke G
    Antimicrob Agents Chemother; 2012 Feb; 56(2):687-96. PubMed ID: 22143518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection?
    Ruf MT; Chauty A; Adeye A; Ardant MF; Koussemou H; Johnson RC; Pluschke G
    PLoS Negl Trop Dis; 2011 Aug; 5(8):e1252. PubMed ID: 21829740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycobacterium ulcerans in the Daintree 2009-2015 and the mini-epidemic of 2011.
    Steffen CM; Freeborn H
    ANZ J Surg; 2018 Apr; 88(4):E289-E293. PubMed ID: 27804194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology, clinical features and diagnosis of Mycobacterium ulcerans in an Australian population.
    Boyd SC; Athan E; Friedman ND; Hughes A; Walton A; Callan P; McDonald A; O'Brien DP
    Med J Aust; 2012 Mar; 196(5):341-4. PubMed ID: 22432674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro antibacterial activity and in vivo efficacy of hydrated clays on Mycobacterium ulcerans growth.
    Adusumilli S; Haydel SE
    BMC Complement Altern Med; 2016 Jan; 16():40. PubMed ID: 26833071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative Genomics Shows That Mycobacterium ulcerans Migration and Expansion Preceded the Rise of Buruli Ulcer in Southeastern Australia.
    Buultjens AH; Vandelannoote K; Meehan CJ; Eddyani M; de Jong BC; Fyfe JAM; Globan M; Tobias NJ; Porter JL; Tomita T; Tay EL; Seemann T; Howden BP; Johnson PDR; Stinear TP
    Appl Environ Microbiol; 2018 Apr; 84(8):. PubMed ID: 29439984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes for Mycobacterium ulcerans infection with combined surgery and antibiotic therapy: findings from a south-eastern Australian case series.
    O'Brien DP; Hughes AJ; Cheng AC; Henry MJ; Callan P; McDonald A; Holten I; Birrell M; Sowerby JM; Johnson PD; Athan E
    Med J Aust; 2007 Jan; 186(2):58-61. PubMed ID: 17223763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.